Search Options Stock News and Analysis from Schaeffer's

Biotech Stocks Blasts Off After Eczema Drug Trial

https://www.schaeffersresearch.com/content/news/2025/06/24/biotech-stocks-blasts-off-after-eczema-drug-trial

6/24/2025 10:53 AM

Biotech stock Nektar Therapeutics Inc (NASDAQ:NKTR) is soaring today, up 83.7% at $17.52 at last glance, after the company's eczema drug, rezpegaldesleukin, met its primary and secondary goals in a ...

Nektar Therapeutics Options Pop as Stock Soars

https://www.schaeffersresearch.com/content/options/2020/01/10/nektar-therapeutics-options-pop-as-stock-soars

1/10/2020 1:34 PM

The shares of Nektar Therapeutics (NASDAQ:NKTR) are pacing for their biggest one-day jump in almost two years after the firm amended its collaboration agreement with Bristol-Myers Squibb (BMY). The t...

Nektar Therapeutics Blasted With Bear Notes During Sell-Off

https://www.schaeffersresearch.com/content/news/2019/08/09/nektar-therapeutics-blasted-with-bear-notes-during-sell-off

8/9/2019 10:04 AM

Nektar Therapeutics (NASDAQ:NKTR) stock opened at its lowest level since mid-2017 today -- down 36% at $18.01 -- after the drugmaker unveiled manufacturing issues with bempeg, its experimental cancer ...

Dow Eyes 3 Straight Wins as Rebound Hits High Gear

https://www.schaeffersresearch.com/content/ezines/2019/05/16/dow-eyes-3-straight-wins-as-rebound-hits-high-gear

5/16/2019 12:06 PM

The Dow Jones Industrial Average (DJI) is soaring today, up over 250 points and barreling toward its third straight win, thanks to a combination of well-received blue-chip earnings and upbeat eco...

Stocks to Buy Before a Fed Rate Hike

https://www.schaeffersresearch.com/content/analysis/2018/12/18/stocks-to-buy-before-a-fed-rate-hike

12/18/2018 2:37 PM

The Federal Open Market Committee (FOMC) kicked off its two-day policy-setting meeting today, with the central bank widely expected to announce another rate hike tomorrow afternoon -- despite protests...

PEOPLE ALSO SEARCH FOR